USRM Stock Price, Chart, Stats & News

U.S. Stem Cell, Inc.
Save
U.S. Stem Cell, Inc. (USRM) does not currently pay a dividend.
64,151
Market cap
–
Current P/E
–
Forward P/E
USRM chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
U. S. Stem Cell, Inc. is a biotechnology firm dedicated to the advancement and commercialization of autologous cellular therapies throughout the United States.
Similar securities
Based on sector and market capitalization
Report issue





